A potential anti-tumor effect of leukotriene C 4  through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells

Lubna M. Mehdawi; Shakti Ranjan Satapathy; Annika Gustafsson; Kent Lundholm; Maria Alvarado-Kristensson; Anita Sjölander

doi:10.18632/oncotarget.16591

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

A potential anti-tumor effect of leukotriene C₄ through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells

Lubna M. Mehdawi, Shakti Ranjan Satapathy, Annika Gustafsson, Kent Lundholm, Maria Alvarado-Kristensson and Anita Sjölander _

PDF | HTML | How to cite

Oncotarget. 2017; 8:35033-35047. https://doi.org/10.18632/oncotarget.16591

Metrics: PDF 1434 views | HTML 1950 views | ?

Abstract

Lubna M. Mehdawi1, Shakti Ranjan Satapathy1, Annika Gustafsson2, Kent Lundholm2, Maria Alvarado-Kristensson3 and Anita Sjölander1

1Cell and Experimental Pathology, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden

2Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

3Molecular Pathology, Department of Translational Medicine, Lund University, Malmö, Sweden

Correspondence to:

Anita Sjölander, email: [email protected]

Keywords: CysLTR2, 15-PGDH, colon cancer, LTC₄ signaling, anti-tumor

Received: December 20, 2016 Accepted: March 03, 2017 Published: March 27, 2017

ABSTRACT

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. Cyclooxygenase-2, which plays a key role in the biosynthesis of prostaglandin E₂ (PGE₂), is often up-regulated in CRC and in other types of cancer. PGE₂ induces angiogenesis and tumor cell survival, proliferation and migration. The tumor suppressor 15-hydroxyprostaglandin dehydrogenase (15-PGDH) is a key enzyme in PGE₂ catabolism, converting it into its inactive metabolite 15-keto-PGE₂, and is often down-regulated in cancer. Interestingly, CRC patients expressing high levels of the cysteinyl leukotriene 2 (CysLT₂) receptor have a good prognosis; therefore, we investigated a potential link between CysLT₂ signaling and the tumor suppressor 15-PGDH in colon cancer cells.

We observed a significant up-regulation of 15-PGDH after treatment with LTC₄, a CysLT₂ ligand, in colon cancer cells at both the mRNA and protein levels, which could be reduced by a CysLT₂ antagonist or a JNK inhibitor. LTC₄ induced 15-PGDH promoter activity via JNK/AP-1 phosphorylation. Furthermore, we also observed that LTC₄, via the CysLT₂/JNK signaling pathway, increased the expression of the differentiation markers sucrase-isomaltase and mucin-2 in colon cancer cells and that down-regulation of 15-PGDH totally abolished the observed increase in these markers.

In conclusion, the restoration of 15-PGDH expression through CysLT₂ signaling promotes the differentiation of colon cancer cells, indicating an anti-tumor effect of CysLT₂ signaling.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16591

Publication Alerts

Research Papers:

A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells

Abstract

A potential anti-tumor effect of leukotriene C₄ through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells